Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules

Hypertension is a diverse illness interlinked with cerebral, cardiovascular (CVS) and renal abnormalities. Presently, the malady is being treated by focusing on Renin- angiotensin system (RAS), voltage-gated calcium channels, peripheral vasodilators, renal and sympathetic nervous systems. Cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramya, Krishnappa, Suresh, Ramalingam, Kumar, Honnavalli Yogish, Kumar, B.R. Prashantha, Murthy, N.B. Sridhara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112834/
https://www.ncbi.nlm.nih.gov/pubmed/32247750
http://dx.doi.org/10.1016/j.bmc.2020.115466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112834/
https://www.ncbi.nlm.nih.gov/pubmed/32247750
http://dx.doi.org/10.1016/j.bmc.2020.115466

Ejemplares similares